Top View
- Statistical Analysis Plan / Data Specifications the Risk of Acute Liver Injury Associated with the Use of Antibiotics. a Replica
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- 6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
- Subtractive Proteomics to Identify Novel Drug Targets and Reverse
- WO 2010/083148 Al
- Nonclassical Biological Activities of Quinolone Derivatives
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Front Matter
- Customs Tariff - Schedule
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- 330 Antibacterials Adverse Effects As for Rifampicin, P.325
- Drug Effect Prediction by Polypharmacology-Based
- Oral Antibiotic Exposure and Kidney Stone Disease
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Administration of a Bowel Cleanser and an Antibiotic for the Treatment of Bowel Disease
- Guidelines for ATC Classification and DDD Assignment 2021
- From Chloroquine to Antineoplastic Drugs? the Story of Antibacterial Quinolones
- Guidelines for ATC Classification and DDD Assignment 2011
- Critically Important Antimicrobials for Human Medicine, 6Th Revision
- (12) Patent Application Publication (10) Pub. No.: US 2008/0220441 A1 Birnbaum Et Al
- WHO List of Critically Important Anti-‐Microbials, 2011 Rev 3
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Antimicrobial Resistance in Neisseria Gonorrhoeae John Tapsall
- Computer Automated Structure Evaluation of Quinolone Antibacterial Agents GILLES KLOPMAN,1* OREST T
- Environmentally Friendly Fluoroquinolone Derivatives with Lower Plasma Protein Binding Rate Designed Using 3D-QSAR, Molecular Do
- Antibiotics in Aquaculture Wastewater: Is It Feasible to Use a Photodegradation-Based Treatment for Their Removal?
- Medical Consult Guide
- (12) Patent Application Publication (10) Pub. No.: US 2004/0131628A1 Bratzler Et Al
- Mechanism of Inhibition of DNA Gyrase by Analogues of Nalidixic Acid
- Resolution Ap (2000) 1
- Norfioxacin: a New Quinolone
- Pharmaceutical Appendix to the Tariff Schedule 2
- Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
- Studies on Mutational Resistance to Nalidixic Acid in Escherichia Coli
- Surveillance of Antimicrobial Consumption in Europe 2012 Surveillance of Antimicrobial Consumption in Europe 2012
- Rosoxacin (BAN, USAN, Rinn) Rifapentine Is a Rifamycin Antibacterial (See Rifampicin, P.325) 7
- Pipemidic Acid: Pde Determination Strategy